Medifast, Inc. (MED)

BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findings based on an online survey conducted by OPTAVIA with KRC Research among a nationally representative group of U.S. adults ages 18–75, recruited to match U.S. Census demographics*. The data highlights a pressing concern: 80% of American adults lack understanding of metabolic health, yet many are e.

BAB (OTCMKTS:BABB - Get Free Report) and Medifast (NYSE: MED - Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Profitability This table compares BAB and Medifast's net

Medifast (NYSE: MED - Get Free Report) and Celsius (NASDAQ: CELH - Get Free Report) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, profitability, earnings, dividends, valuation, analyst recommendations and institutional ownership. Institutional and Insider Ownership 95.5% of Medifast shares are

Medifast (NYSE: MED - Get Free Report) and Marzetti (NASDAQ: MZTI - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations. Dividends Medifast pays an annual dividend of $6.60 per

Acadian Asset Management LLC increased its stake in shares of Medifast Inc (NYSE: MED) by 6.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 411,101 shares of the specialty retailer's stock after purchasing an additional 25,378 shares during the period.

BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis of metabolic dysfunction by unveiling new research findings during ObesityWeek. Hosted by The Obesity Society in Atlanta, Georgia November 4–7, 2025, the annual conference for obesity researchers and clinicians centers on the latest developments in evidence-based obesity science: cutting-edge basic.

Medifast (NYSE: MED - Get Free Report) and Celsius (NASDAQ: CELH - Get Free Report) are both consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk. Insider and Institutional Ownership 95.5% of Medifast shares are

MED's third-quarter results reflect pressure from fewer active OPTAVIA Coaches, but it is steering toward metabolic health for growth.

Medifast, Inc. ( MED ) Q3 2025 Earnings Call November 3, 2025 4:30 PM EST Company Participants Steven Zenker - Vice President of Investor Relations Daniel Chard - Executive Chairman & CEO James Maloney - Chief Financial Officer Nicholas Johnson - Chief Field Operations Officer Conference Call Participants James Salera - Stephens Inc., Research Division Presentation Operator Greetings, and welcome to the Medifast Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended September 30, 2025. Third Quarter 2025 Revenue: $89.4 million, with revenue per active earning coach of $4,585 Active Coaches: Independent active earning OPTAVIA® coaches of 19,500 Net Loss: $2.3 million or $0.21 loss per diluted share Strong Balance Sheet: $173.5 million in cash, cash equivalents, and i.

Cwm LLC raised its position in Medifast Inc (NYSE: MED) by 564.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,457 shares of the specialty retailer's stock after acquiring an additional 6,335 shares during the quarter. Cwm LLC owned approximately 0.07% of

Medifast (NYSE: MED - Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Monday, November 3rd. Analysts expect Medifast to post earnings of ($0.01) per share and revenue of $84.10 million for the quarter. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS.Individuals may visit the the company's

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a new focus on holistic metabolic health. The company introduced Metabolic Synchronization™ — a breakthrough science that reverses metabolic dysfunction with a targeted reset of the body's metabolism. Research shows the company's comprehensive system activates strong and targeted fat burn to improve m.

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter ended September 30, 2025 on Monday, November 3, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.

MED boosts growth efforts with new products, digital tools and an expanded OPTAVIA coaching network.